Xin Ma
Personalreferent bei 3SBIO INC.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Jing Lou | M | 61 |
Shanghai Xingsheng Pharmaceutical Co., Ltd.
 Shanghai Xingsheng Pharmaceutical Co., Ltd. Financial ConglomeratesFinance Shanghai Xingsheng Pharmaceutical Co., Ltd. engages in the investment and transfer of technologies. Its business includes research and development of biological products, genetic engineering products, Chinese and western medicines, and biochemical reagents. The company was founded on December 23, 1998 and is headquartered in Shanghai, China.
Shenyang Sunshine Pharmaceuticals Co., Ltd.
 Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | 31 Jahre |
| Bin Huang | M | 63 |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | 31 Jahre |
| Dong Mei Su | M | 54 |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | 31 Jahre |
| Bo Tan | M | 51 |
Shanghai Xingsheng Pharmaceutical Co., Ltd.
Shanghai Xingsheng Pharmaceutical Co., Ltd. Financial ConglomeratesFinance Shanghai Xingsheng Pharmaceutical Co., Ltd. engages in the investment and transfer of technologies. Its business includes research and development of biological products, genetic engineering products, Chinese and western medicines, and biochemical reagents. The company was founded on December 23, 1998 and is headquartered in Shanghai, China.
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | 15 Jahre |
| Tian Ruo Pu | M | 55 | 9 Jahre | |
| Dan Zhang | M | 60 | 2 Jahre | |
| Joo Yeow Ng | M | 59 | 2 Jahre | |
| Hoi Ti Yang | F | 54 | 3 Jahre | |
| Xin Ma | M | - |
Shanghai Xingsheng Pharmaceutical Co., Ltd.
Shanghai Xingsheng Pharmaceutical Co., Ltd. Financial ConglomeratesFinance Shanghai Xingsheng Pharmaceutical Co., Ltd. engages in the investment and transfer of technologies. Its business includes research and development of biological products, genetic engineering products, Chinese and western medicines, and biochemical reagents. The company was founded on December 23, 1998 and is headquartered in Shanghai, China. | - |
| Yuan Yuan Ren | M | - | - | |
| Dong Tao Luo | M | 48 | 8 Jahre | |
| Hui Dang | F | 52 |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | 25 Jahre |
| Ping Zhou | F | - |
Shanghai Xingsheng Pharmaceutical Co., Ltd.
Shanghai Xingsheng Pharmaceutical Co., Ltd. Financial ConglomeratesFinance Shanghai Xingsheng Pharmaceutical Co., Ltd. engages in the investment and transfer of technologies. Its business includes research and development of biological products, genetic engineering products, Chinese and western medicines, and biochemical reagents. The company was founded on December 23, 1998 and is headquartered in Shanghai, China. | - |
| Hui Hui Li | F | 43 |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | 11 Jahre |
| Yong Fu Chen | M | 67 |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | 21 Jahre |
| Siu Kuen Lai | F | 48 | 2 Jahre | |
| Ke Li | M | 56 |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | 31 Jahre |
| Xiang He | M | - | 1 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Wei Xing Wang | M | 60 |
Tianjin Medical University
| 3 Jahre |
| Yue Wu | F | 45 |
Guangdong Pfizer Investment Co., Ltd.
 Guangdong Pfizer Investment Co., Ltd. Financial ConglomeratesFinance Part of Pfizer Inc., Guangdong Pfizer Investment Co., Ltd. provides investment services. The company is based in Beijing, China. | 4 Jahre |
| Wei Hong Xiao | M | 56 |
Hisun Pfizer Pharmaceuticals Co., Ltd.
 Hisun Pfizer Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Hisun Pfizer Pharmaceuticals Co., Ltd. engages in the development, production, marketing, and sale of pharmaceutical products. It offers medicine in the form of tablets, hard capsules, and injection. The company was founded on September 6, 2012 and is headquartered in Hangzhou, China. | 3 Jahre |
| Jian Kong | M | 61 |
Tianjin Medical University
| 1 Jahre |
| Wei Zhang | M | 57 |
Tianjin Medical University
| 4 Jahre |
| Jinbo Wang | M | 50 |
Hisun Pfizer Pharmaceuticals Co., Ltd.
Hisun Pfizer Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Hisun Pfizer Pharmaceuticals Co., Ltd. engages in the development, production, marketing, and sale of pharmaceutical products. It offers medicine in the form of tablets, hard capsules, and injection. The company was founded on September 6, 2012 and is headquartered in Hangzhou, China. | 8 Jahre |
| Qin Xie | M | 44 |
Hisun Pfizer Pharmaceuticals Co., Ltd.
Hisun Pfizer Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Hisun Pfizer Pharmaceuticals Co., Ltd. engages in the development, production, marketing, and sale of pharmaceutical products. It offers medicine in the form of tablets, hard capsules, and injection. The company was founded on September 6, 2012 and is headquartered in Hangzhou, China. | 2 Jahre |
| Shi Dong Jiang | M | 57 |
Hisun Pfizer Pharmaceuticals Co., Ltd.
Hisun Pfizer Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Hisun Pfizer Pharmaceuticals Co., Ltd. engages in the development, production, marketing, and sale of pharmaceutical products. It offers medicine in the form of tablets, hard capsules, and injection. The company was founded on September 6, 2012 and is headquartered in Hangzhou, China. | - |
| Xiao Gang Wang | M | 51 |
Beijing Novartis Pharma Ltd.
 Beijing Novartis Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Beijing Novartis Pharma Ltd. is a pharmaceutical company. The company is based in Beijing, China. Founded in 1987, it operates in the pharmaceutical industry. | 4 Jahre |
| Yong Yue | M | 63 |
Tianjin Medical University
| 1 Jahre |
| Ye Shi Liang | M | 74 |
Tianjin Medical University
| 1 Jahre |
| Peng Wang | M | 62 |
Tianjin Medical University
| 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| China | 22 | 73,33% |
| Cayman Islands | 11 | 36,67% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
